Chemoinformaics analysis of Tritriacontane-12,14-dione
Molecular Weight | 492.873 | nRot | 30 |
Heavy Atom Molecular Weight | 428.361 | nRig | 2 |
Exact Molecular Weight | 492.491 | nRing | 0 |
Solubility: LogS | -6.657 | nHRing | 0 |
Solubility: LogP | 12.052 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 99 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 33 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 99.3888 |
nHD | 0 | BPOL | 65.9412 |
QED | 0.074 |
Synth | 1.919 |
Natural Product Likeliness | 0.397 |
NR-PPAR-gamma | 0.966 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.007 |
CACO-2 | -5.398 |
MDCK | 0.00000401 |
BBB | 0.002 |
PPB | 0.972517 |
VDSS | 1.772 |
FU | 0.00538582 |
CYP1A2-inh | 0.033 |
CYP1A2-sub | 0.14 |
CYP2c19-inh | 0.108 |
CYP2c19-sub | 0.04 |
CYP2c9-inh | 0.03 |
CYP2c9-sub | 0.986 |
CYP2d6-inh | 0.032 |
CYP2d6-sub | 0.011 |
CYP3a4-inh | 0.196 |
CYP3a4-sub | 0.014 |
CL | 5.101 |
T12 | 0.166 |
hERG | 0.409 |
Ames | 0.009 |
ROA | 0.01 |
SkinSen | 0.967 |
Carcinogencity | 0.024 |
EI | 0.916 |
Respiratory | 0.977 |
NR-Aromatase | 0.037 |
Antiviral | No |
Prediction | 0.542542 |